SEC 13F Intelligence

Managers / Q4 2019 · view latest →

Mohican Financial Management, LLC

CIK 0001367663 · 21 RIVER RD, SUITE 2100, WILTON, CT, 06897 · 203-423-8029

Reported Value
$64M
Q4 2019
Positions
40
Filings on Record
11
2019–present window
Filed
Jan 28, 2020
original filing

Summary

Mohican Financial Management, LLC reported $64M in U.S.-listed holdings across 40 positions for Q4 2019.

Its largest position, Five9, represents 5.3% of the portfolio.

Compared with Q3 2019, the fund opened 3 new positions and exited 9.

Portfolio Metrics

Turnover
+20.2%
vs prior filed quarter
Top-10 Concentration
+44.4%
share of reported value
Largest Position
+5.3%
Five9
New / Exited
3 / 9
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $24MQ4 ’18Q1 ’19: $31MQ2 ’19: $68MQ2 ’19Q3 ’19: $65MQ4 ’19: $64MQ4 ’19Q1 ’20: $70MQ2 ’20: $55MQ2 ’20Q3 ’20: $80MQ4 ’20: $98MQ4 ’20Q1 ’21: $154MQ2 ’21: $256MQ2 ’21filingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 98.9%GLOBAL: 1.1%
  • US DOMESTIC · 98.9% · $63M
  • GLOBAL · 1.1% · $688,000

Quarter-over-Quarter Changes full breakdown →

vs Q3 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PERFICIENT INCNEW+2.00M2.00M+$3M$3M
EVOLENT HEALTH INCNEW+1.00M1.00M+$688,000$688,000
SUPERNUS PHARMACEUTICALS INCNEW+500.0K500.0K+$453,000$453,000
MESA LABS INCADDED+1.50M2.20M+$2M$2M
FLEXION THERAPEUTICS INCADDED+975.0K1.60M+$1M$2M
NXP SEMICONDUCTORS N VSOLD OUT−1.50M0−$2M$0
PROS HOLDINGS INCSOLD OUT−1.00M0−$1M$0
INSMED INCSOLD OUT−1.50M0−$1M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2019

37 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1FIVE9 INCNOTE 0.125% 5/05.26%$3M2.00M
2CHEGG INCNOTE 0.250% 5/14.72%$3M2.00M
3Q2 HLDGS INCNOTE 0.750% 2/14.71%$3M2.00M
4ENVESTNET INCNOTE 1.750% 6/04.68%$3M2.50M
5MERCADOLIBRE INCNOTE 2.000% 8/14.66%$3M2.00M
6INSULET CORPNOTE 1.375%11/14.49%$3M1.51M
7AEROJET ROCKETDYNE HLDGS INCNOTE 2.250%12/14.24%$3M1.50M
8PERFICIENT INCNOTE 2.375% 9/14.24%$3M2.00M
9MESA LABS INCNOTE 1.375% 8/13.74%$2M2.20M
10TTM TECHNOLOGIES INCNOTE 1.750%12/13.70%$2M1.50M
11EXACT SCIENCES CORPNOTE 1.000% 1/13.52%$2M1.56M
12KAMAN CORPNOTE 3.250% 5/03.47%$2M1.86M
13FIREEYE INCNOTE 0.875% 6/0 · NOTE 1.625% 6/03.46%$2M2.25M
14INFINERA CORPORATIONNOTE 2.125% 9/03.29%$2M2.00M
15TWITTER INCNOTE 1.000% 9/1 · NOTE 0.250% 6/13.25%$2M2.15M
16HELIX ENERGY SOLUTIONS GRP INOTE 4.125% 9/13.02%$2M1.50M
17FTI CONSULTING INCNOTE 2.000% 8/12.93%$2M1.50M
18LIVE NATION ENTERTAINMENT INNOTE 2.500% 3/12.86%$2M1.50M
19FLEXION THERAPEUTICS INCNOTE 3.375% 5/02.61%$2M1.60M
20VISHAY INTERTECHNOLOGY INCNOTE 2.250% 6/12.46%$2M1.57M
21ENCORE CAP GROUP INCNOTE 2.875% 3/1 · NOTE 3.000% 7/02.44%$2M1.59M
22NEWPARK RES INCNOTE 4.000%12/02.41%$2M1.50M
23ALTAIR ENGR INCNOTE 0.250% 6/02.40%$2M1.50M
24VOCERA COMMUNICATIONS INCNOTE 1.500% 5/12.30%$1M1.50M
25SILICON LABORATORIES INCNOTE 1.375% 3/02.07%$1M1.00M
26KNOWLES CORPNOTE 3.250%11/02.04%$1M1.00M
27GUIDEWIRE SOFTWARE INCNOTE 1.250% 3/11.84%$1M1.00M
28PACIRA BIOSCIENCESNOTE 2.375% 4/01.62%$1M1.00M
29RETROPHIN INCNOTE 2.500% 9/11.21%$778,0001.00M
30EVOLENT HEALTH INCNOTE 1.500%10/11.07%$688,0001.00M
31VEECO INSTRS INC DELNOTE 2.700% 1/11.01%$650,000691.0K
32SILVER STD RES INCNOTE 2.875% 2/01.01%$646,000639.0K
33THERAVANCE BIOPHARMA INCNOTE 3.250%11/00.81%$517,000500.0K
34TEAM INCNOTE 5.000% 8/00.76%$487,000467.0K
35SUPERNUS PHARMACEUTICALS INCNOTE 0.625% 4/00.71%$453,000500.0K
36TIMKENSTEEL CORPNOTE 6.000% 6/00.68%$435,000425.0K
37GLOBAL EAGLE ENTMT INCNOTE 2.750% 2/10.31%$200,000500.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2021$256M70Jul 28, 202113F-HRchanges · EDGAR ↗
Q1 2021$154M51Apr 29, 202113F-HRchanges · EDGAR ↗
Q4 2020$98M46Jan 14, 202113F-HRchanges · EDGAR ↗
Q3 2020$80M47Oct 20, 202013F-HRchanges · EDGAR ↗
Q2 2020$55M40Jul 20, 202013F-HRchanges · EDGAR ↗
Q1 2020$70M47Apr 29, 202013F-HRchanges · EDGAR ↗
Q4 2019$64M40Jan 28, 202013F-HRchanges · EDGAR ↗
Q3 2019$65M46Oct 25, 201913F-HRchanges · EDGAR ↗
Q2 2019$68M49Jul 11, 201913F-HRchanges · EDGAR ↗
Q1 2019$31M31Apr 23, 201913F-HRchanges · EDGAR ↗
Q4 2018$24M30Jan 29, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.